APA

Hassan R., Ebel W., Routhier E. L., Patel R., Kline J. B., Zhang J., Chao Q., Jacob S., Turchin H., Gibbs L., Phillips M. D., Mudali S., Iacobuzio-Donahue C., Jaffee E. M., Moreno M., Pastan I., Sass P. M., Nicolaides N. C. & Grasso L. (20080201). Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. : Cancer immunity.

Chicago

Hassan Raffit, Ebel Wolfgang, Routhier Eric L, Patel Rina, Kline J Bradford, Zhang Jingli, Chao Qimin, Jacob Sara, Turchin Howard, Gibbs Lester, Phillips Martin D, Mudali Shiyama, Iacobuzio-Donahue Christine, Jaffee Elizabeth M, Moreno Maria, Pastan Ira, Sass Philip M, Nicolaides Nicholas C and Grasso Luigi. 20080201. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. : Cancer immunity.

Harvard

Hassan R., Ebel W., Routhier E. L., Patel R., Kline J. B., Zhang J., Chao Q., Jacob S., Turchin H., Gibbs L., Phillips M. D., Mudali S., Iacobuzio-Donahue C., Jaffee E. M., Moreno M., Pastan I., Sass P. M., Nicolaides N. C. and Grasso L. (20080201). Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. : Cancer immunity.

MLA

Hassan Raffit, Ebel Wolfgang, Routhier Eric L, Patel Rina, Kline J Bradford, Zhang Jingli, Chao Qimin, Jacob Sara, Turchin Howard, Gibbs Lester, Phillips Martin D, Mudali Shiyama, Iacobuzio-Donahue Christine, Jaffee Elizabeth M, Moreno Maria, Pastan Ira, Sass Philip M, Nicolaides Nicholas C and Grasso Luigi. Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. : Cancer immunity. 20080201.